Articles

Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia

Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica; Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Department of Physiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Department of Laboratory Medicine; Division of Hematology and Department of Internal Medicine; National Taiwan University, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Institute of Biomedical Sciences, Academia Sinica, Taipei
Department of Medical Research and Education, Taipei Medical University, Shuang Ho Hospital, New Taipei City
Department of Laboratory Medicine; Division of Hematology and Department of Internal Medicine; National Taiwan University, Taipei
Division of Hematology and Department of Internal Medicine; National Taiwan University, Taipei
Department of Laboratory Medicine; Division of Hematology and Department of Internal Medicine; National Taiwan University, Taipei
Division of Hematology and Department of Internal Medicine; National Taiwan University, Taipei
Taiwan International Graduate Program in Molecular Medicine, National Yang Ming Chiao Tung University and Academia Sinica; Taipei, Taiwan; Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan; Biomedical Translation Research Center, Academia Sinica, Taipei, Taiwan; Ph.D. Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei
Vol. 108 No. 5 (2023): May, 2023 https://doi.org/10.3324/haematol.2022.281151